PALO

Inpixon Announces Anticipated Closing Date for XTI Merger and Share Consolidation

Retrieved on: 
Monday, March 11, 2024

PALO ALTO, Calif., March 11, 2024 /PRNewswire/ -- Inpixon® (Nasdaq: INPX) ("Inpixon" or the "Company") today announced that the Company and XTI Aircraft Company anticipate the closing date of the previously announced merger will be after market close on March 12, 2024. Following closing, the Company will operate under the name "XTI Aerospace, Inc." ("XTI Aerospace"). Immediately prior to the closing of the transaction, the Company will  implement a consolidation of the Company's common stock for the purpose of satisfying initial listing requirements for the combined company and to bring the company into compliance with Nasdaq continued listing rules. The consolidation will be effective as of market open on March 13, 2024, upon which trading will commence on the Nasdaq Capital Market under the new ticker symbol "XTIA", with a new CUSIP number, 98423K108. Concurrent with the transaction closing, it is expected that an entity controlled by Inpixon's CEO will invest $1.5 million in an equity financing in the Company.

Key Points: 
  • XTI Aerospace Anticipated to Begin Trading on Nasdaq Under Ticker Symbol "XTIA" as of Market Open March 13, 2024
    PALO ALTO, Calif., March 11, 2024 /PRNewswire/ -- Inpixon® (Nasdaq: INPX) ("Inpixon" or the "Company") today announced that the Company and XTI Aircraft Company anticipate the closing date of the previously announced merger will be after market close on March 12, 2024.
  • Following closing, the Company will operate under the name "XTI Aerospace, Inc." ("XTI Aerospace").
  • Concurrent with the transaction closing, it is expected that an entity controlled by Inpixon's CEO will invest $1.5 million in an equity financing in the Company.
  • Any fractional shares resulting from the consolidation will be rounded up to the nearest whole share of common stock.

Remote.It Launches Channel Partner Program for Networking Connectivity Management

Retrieved on: 
Monday, March 11, 2024

PALO ALTO, Calif., March 11, 2024 /PRNewswire/ -- Remote.It, a leading SaaS-based network connectivity management platform, today announced the launch of its channel-focused full reseller program for businesses looking to leverage its remote networking service capabilities. Remote.It's technology allows companies to replace manual network management with instant, secure, and code-based networking that provides seamless network connectivity across all IoT devices and services.

Key Points: 
  • PALO ALTO, Calif., March 11, 2024 /PRNewswire/ -- Remote.It , a leading SaaS-based network connectivity management platform, today announced the launch of its channel-focused full reseller program for businesses looking to leverage its remote networking service capabilities.
  • Remote.It's technology allows companies to replace manual network management with instant, secure, and code-based networking that provides seamless network connectivity across all IoT devices and services.
  • "Remote.It simplifies account and permission management for cloud and on-premise servers, including management of IoT and OT devices."
  • Remote.It partners in the program are able to offer their customers the following benefits:
    Simplify connectivity - connect over complex networks without networking knowledge of configuration.

PayToMe.co Elevates Fintech Ecosystem as Official Plaid Partner

Retrieved on: 
Monday, March 11, 2024

PALO ALTO, Calif., March 11, 2024 /PRNewswire/ -- In a groundbreaking move set to redefine the fintech landscape, PayToMe.co, an international award-winning Digital Payment Platform and strategic partner of NASDAQ-listed AppTech Payments Corp., proudly announces its strategic partnership with Plaid, the world's leading financial data network. This alliance is poised to revolutionize the way businesses across the globe, particularly within the e-commerce, travel, and hospitality sectors, engage with financial data services, marking a new era of secure, seamless, and innovative financial solutions.

Key Points: 
  • Leveraging the impactful alliances Plaid formed with industry giants like Okta, Fiserv, Treasury Prime, and Riskified, PayToMe.co now offer unprecedented access to Plaid's sophisticated financial data sharing technology.
  • Elevated into Plaid's prestigious Partner Directory as a Platform Partner and Reseller Partner, PayToMe.co is sparking a new era of fintech solutions for international markets.
  • This partnership is more than an alliance; it's a launchpad for global fintech innovation."
  • This offering allows businesses to harness PayToMe.co's innovative digital payment solutions alongside real-time financial data from Plaid.

Mega Matrix Announced its Plan to Launch $100 Million “Mars Content Initiative” for Next Three Years

Retrieved on: 
Friday, March 8, 2024

Seamlessly integrated into series, each episode contributes to complete storylines unfolding across 40 to over 100 episodes.

Key Points: 
  • Seamlessly integrated into series, each episode contributes to complete storylines unfolding across 40 to over 100 episodes.
  • Short dramas usually offer viewers a virtual escape, presenting narratives that resonate with emotions, and fostering a sense of connection.
  • With its Mars Content Initiative, Mega Matrix Corp. is not only expanding its content library but also reinforcing its optimistic outlook on the short drama industry's future.
  • FlexTV has already formed a mature content business model that integrates content production, distribution, and operation.

Mega Matrix Announced the Publishing of the Article from MIT Technology Review highlighting FlexTV

Retrieved on: 
Thursday, March 7, 2024

The production company behind this compelling piece, FlexTV, is now garnering public attention.

Key Points: 
  • The production company behind this compelling piece, FlexTV, is now garnering public attention.
  • Recently, an article from the MIT Technology Review was published, spotlighting the rise of short dramas, particularly highlighting FlexTV, which is operated by Yuder Pte, Ltd., an indirect majority-controlled subsidiary of Mega Matrix Corp., a company listed in NYSE American with the ticker symbol MPU.
  • The article admirably introduced and thoroughly analyzed the emerging market of short dramas, providing valuable insights into this innovative industry's potential.
  • Yucheng Hu, the CEO of Mega Matrix Corp., shared his thoughts, stating, "The article in MIT Technology Review provides invaluable insights into the burgeoning market of short dramas, shedding light on its rapid growth and promising future.

Broadcom Extends AI Workload Scale with Industry-First PCI Express Gen5/Gen6 Retimers

Retrieved on: 
Wednesday, March 6, 2024

Broadcom’s investment and deployment scale, along with deep SerDes, protocol and software expertise, are the foundation for industry-leading PCIe switches and retimers.

Key Points: 
  • Broadcom’s investment and deployment scale, along with deep SerDes, protocol and software expertise, are the foundation for industry-leading PCIe switches and retimers.
  • “PCIe is one of the most critical and widely-adopted protocols for interconnecting CPUs, AI accelerators, NICs and storage devices.
  • Broadcom is also committed to accelerate the open AI ecosystem further with PCIe Gen7 based solutions in the near future.
  • Broadcom Architecture: 50% lower power and form factor flexibility with midplane/backplane/cables enable customers to create advanced AI sub-systems.

BridgeBio Pharma Announces Pricing of Public Offering of Common Stock

Retrieved on: 
Wednesday, March 6, 2024

PALO ALTO, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio”), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, today announced the pricing on March 5, 2024 of an underwritten public offering of 8,620,690 shares of its common stock at a public offering price of $29.00 per share, before deducting underwriting discounts and commissions.

Key Points: 
  • PALO ALTO, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio”), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, today announced the pricing on March 5, 2024 of an underwritten public offering of 8,620,690 shares of its common stock at a public offering price of $29.00 per share, before deducting underwriting discounts and commissions.
  • In addition, BridgeBio has granted the underwriters a 30-day option to purchase up to an additional 1,293,103 shares of its common stock on the same terms and conditions.
  • All of the shares in the offering to be sold by BridgeBio.
  • The shares of common stock are being offered by BridgeBio pursuant to an effective shelf registration statement on Form S-3ASR (File No.

Bearing AI Launches EU ETS Compliance Tool

Retrieved on: 
Wednesday, March 6, 2024

Compliance with EU ETS is an imposing challenge for the maritime sector.

Key Points: 
  • Compliance with EU ETS is an imposing challenge for the maritime sector.
  • Bearing AI is meeting this challenge head-on with a new EUA forecast and simulation capability.
  • When uploading a vessel schedule to the FDO platform, our advanced AI provides a projection of specific vessels’ EU ETS obligations for that schedule.
  • This refined tool not only aids in navigating the immediate financial landscape shaped by the EU ETS but also aligns with long-term environmental stewardship by facilitating proactive carbon footprint management.

Vincerx to Present Three Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024

Retrieved on: 
Tuesday, March 5, 2024

PALO ALTO, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced it will present three posters at the American Association for Cancer Research (AACR) Annual Meeting 2024, taking place in San Diego, CA, from April 5 – 10, 2024.

Key Points: 
  • PALO ALTO, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced it will present three posters at the American Association for Cancer Research (AACR) Annual Meeting 2024, taking place in San Diego, CA, from April 5 – 10, 2024.
  • Vincerx will also share clinical data for VIP236 at the conference.
  • To date, 20 patients with relapsed/refractory advanced or metastatic solid tumors have been treated with two different dosing schedules of VIP236.
  • The event will be webcast live, and details can be accessed in the Investor Calendar section of the Vincerx website on March 27, 2024.

Scilex Holding Company Announces Closing of $10 Million Bought Deal Offering

Retrieved on: 
Tuesday, March 5, 2024

Rodman & Renshaw LLC and StockBlock Securities LLC were the underwriters and acted as the joint book-running managers for the offering.

Key Points: 
  • Rodman & Renshaw LLC and StockBlock Securities LLC were the underwriters and acted as the joint book-running managers for the offering.
  • The Company has granted to the underwriters a 30-day option to purchase up to an additional 882,352 shares of common stock and/or Common Warrants at the public offering price, less underwriting discounts and commissions.
  • The gross proceeds to the Company, before deducting underwriting discounts and commissions and offering expenses and assuming no exercise of the underwriters’ option to purchase additional shares of common stock and/or Common Warrants, were approximately $10 million.
  • The securities described above were offered by the Company pursuant to a “shelf” registration statement on Form S-3 (File No.